Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded a new publication entry to the Publications section: Blauvelt A, et al. Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies. Dermatol Ther (Heidelb). 2026 Feb 12. doi: 10.1007/s13555-025-01639-0. Online ahead of print.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision: v3.4.2 has been added, replacing the previous v3.4.1. This is a minor update and does not affect study content or access to information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedThe locations listing was expanded to include numerous new sites across the United States, Canada, and Europe, and the revision version was updated to v3.3.3.SummaryDifference2%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.